March 29, 2024

FDA’s hearing-aid guidance clears regulatory review amid push by lawmakers for OTC sales – MedTech Dive

Listen to the article
2 min

This audio is auto-generated. Please let us know if you have feedback.

Dive Brief:

The Food and Drug Administration’s final guidance on the regulatory requirements for hearing-aid devices and personal sound amplification products has taken a step toward publication. Th…….

This audio is auto-generated. Please let us know if you have feedback.

Dive Brief:

  • The Food and Drug Administration’s final guidance on the regulatory requirements for hearing-aid devices and personal sound amplification products has taken a step toward publication. The guidance would create a new category of over-the-counter hearing aids, after Congress passed a law in 2017 requiring the FDA to allow for retail sales of the devices for adults with mild- to moderate-hearing loss.
  • On Friday, the Office of Information and Regulatory Affairs completed its review of the guidance. The OIRA found the document to be consistent with the principles set out in an executive order on regulatory planning, while changes have been made since the FDA sent it for review.
  • At this stage, the nature and extent of the changes are not known publicly. The FDA is under pressure from lawmakers who want it to swiftly sign off on retail sales of hearing aids.

Dive Insight:

The FDA submitted the guidance to the OIRA on July 8. Later that month, representatives of the OIRA, the FDA and other bodies met to discuss the regulatory requirements. The OIRA delivered its verdict on Aug. 5, less than 30 days after receiving the guidance. An executive order that sets out the role of the OIRA gives the office as many as 90 days to review regulations. 

Few details on the review have been provided so far other than the guidance was coded as “consistent with change.”  According to the Center for Effective Government, the term means<…….

Source: https://www.medtechdive.com/news/fda-OTC-hearing-aid-guidance-clears-regulatory-review/629157/